코스모스헬스(COSM) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

Q: What kind of company is 코스모스헬스(COSM)?

코스모스헬스(COSM) belongs to the Healthcare sector and operates in the Medical Distribution industry.

Q: What is the market cap of COSM?

The market cap of COSM is approximately $13M, ranking 5,416 within its sector.

Q: What is the 52-week high and low for COSM?

COSM has recorded a 52-week high of $1.32 and a low of $0.16.

COSM

Cosmos Health Inc

7월 27일 4:00 PM ET (한국 7/28 05:00)

$0.20

+0.00 +2.40%

🌙 7월 28일 5:21 AM ET (한국 7/28 18:21)

$0.20

-0.01 ▼ -4.44%

코스모스헬스(COSM) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$13M

스몰캡

P/E

배당수익률

없음

52주 위치

저점 +27% · 고점 -84%

애널리스트

적극 매수

Fundamental health

vs. Healthcare 초소형주· based on 3 axes

수익성

산출 불가 (적자)

성장

Top 20%

밸류에이션

Top 88%

재무 안정

Top 57%

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-0.65	Insider Own ⓘ	67.49%	Shs Outstand ⓘ	49.8M	Perf Week ⓘ	-11.12%
Market Cap ⓘ	0.01B	Forward P/E ⓘ	2.92	EPS next Y ⓘ	600%	Insider Trans ⓘ	4.41%	Shs Float ⓘ	20.2M	Perf Month ⓘ	10.47%
Enterprise Value ⓘ	0.03B	PEG ⓘ	-	EPS next Q ⓘ	0.01	Inst Own ⓘ	2.37%	Short Float ⓘ	27.73%	Perf Quarter ⓘ	-46.1%
Income ⓘ	-0.02B	P/S ⓘ	0.18	EPS this Y ⓘ	101.59%	Inst Trans ⓘ	-0.71%	Short Ratio ⓘ	0.61	Perf Half Y ⓘ	-58.91%
Sales ⓘ	0.07B	P/B ⓘ	0.51	EPS next 5Y ⓘ	-	ROA ⓘ	-35.35%	Short Interest ⓘ	5.60M	Perf YTD ⓘ	-58.9%
Book/sh ⓘ	0.4	P/C ⓘ	5.8	EPS past 3/5Y ⓘ	73.29% -	ROE ⓘ	-92.33%	52W High ⓘ	-84.49% ($1.32)	Perf Year ⓘ	-70.61%
Cash/sh ⓘ	0.04	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	9.04% 3.33%	ROIC ⓘ	-80%	52W Low ⓘ	26.67% ($0.16)	Perf 3Y ⓘ	-87.21%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	37.35%	Gross Margin ⓘ	8.39%	Volatility(W/M) ⓘ	12.11% 17.24%	Perf 5Y ⓘ	-99.81%
Dividend TTM ⓘ	-	EV/Sales ⓘ	0.42	Sales Y/Y TTM ⓘ	29.75%	Oper. Margin ⓘ	-25.75%	ATR (14) ⓘ	0.03	Perf 10Y ⓘ	-99.88%
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	0.92	EPS Q/Q ⓘ	-89.81%	Profit Margin ⓘ	-30.41%	RSI (14) ⓘ	40.37	Recom ⓘ	1
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	1.08	Sales Q/Q ⓘ	30.74%	SMA20 ⓘ	-14.87% ($0.23)	Beta ⓘ	4.15	Target Price ⓘ	$4.5
Payout ⓘ	-	Debt/Eq ⓘ	0.93	Earnings ⓘ	2026/5/21	SMA50 ⓘ	-15.6% ($0.24)	Rel Volume ⓘ	0.29	Prev Close ⓘ	$0.2
Employees ⓘ	163	LT Debt/Eq ⓘ	0.33	EPS/Sales Surpr. ⓘ	- -0.16%	SMA200 ⓘ	-54.68% ($0.44)	Avg Volume(3M) ⓘ	9.22M	Price ⓘ	$0.2
IPO ⓘ	2010/7/23	Option/Short ⓘ	Yes/Yes			Trades ⓘ	2109	Volume ⓘ	2,716,885	Change ⓘ	2.4%

Quarterly earnings trend SEC filings · USD

24.6

24.9

24.12*

25.3

25.6

25.9

25.12*

26.3

Revenue Net income 최근 분기: 매출 $18M (YoY +31%) · 순이익 $-3M (YoY -243%)

* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Cosmos Health Inc (COSM) Investment Analysis

What kind of company is Cosmos Health Inc?

코스모스헬스(COSM)

Healthcare · Medical Distribution

Small-Cap — Low Volume, High Volatility

💊 It is a Greece-based, vertically integrated healthcare group. The structure combines pharmaceutical and health-functional food wholesale distribution, CMO/CDMO production at its own factory (Cana Laboratories), sales of its own brands such as Sky Premium Life, and a UK-based wholesale subsidiary, making it one of the European small-cap healthcare companies with notably strong growth momentum.

Learn more about Cosmos Health Inc →

Market Cap

$0.0B

Approx. KRW 0.0 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank5416

Employees163people

IPO2010/07/23

Current Price$0.20 ≈ 274원

NASD · Greece

Key Events

⏰ Upcoming events

🔔 Earnings release

The next release date has not been announced yet.

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🔔 Earnings release 2026년 5월 21일 (목) · 장 시작 전 EPS +0.0% 매출 -0.2%

🔔 Earnings release 2026년 4월 15일 (수) · 장 시작 전 EPS -725.0% 매출 +4.7%

🔔 Earnings release 2025년 11월 17일 (월) · 장 시작 전

Is it profitable?

Profitability weak

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

-25.8%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Net Margin

Share of revenue left after taxes and interest are paid

-30.4%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

8.4%

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 초소형주 Median 42.6% · Bottom 27%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

-92.3%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROA

Annual earnings relative to total company assets

-35.4%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

ROIC

Return generated per dollar invested in the business

-80.0%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.93

✓ Average

My positionMid-range

Low range Average High range

Healthcare 초소형주 Median 0.09

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

1.08

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 초소형주 Median 2.76

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

0.92

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 초소형주 Median 2.54

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook

Price targets, growth, and valuation are favorable

애널리스트 목표가

$4.50

현재가 대비 +2150.0%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

예상 PER (Forward)

2.92배

💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인

내년 EPS 예상 성장률

+600.0%

💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Volatility

Frequently misses analyst estimates

예상 상회

예상 부합

예상 하회

상회 비율

-404.9%

평균 서프라이즈

2026.05.21

부합

+0.0%

2026.04.15

하회

실적 $-0.36 · 예상 $-0.04 -809.8%

💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Strong Growth

Above the industry average, both historically and going forward

🔮 How much will it grow? (analyst forecasts)

This Year's EPS Outlook

Projected EPS growth rate for this year

+101.6%

우수

My positionTop 25%

Low range Average High range

미분류 초소형주 Median 29.4% · Top 16%

Next Year's EPS Outlook

Projected EPS growth rate for next year (analyst consensus)

+600.0%

우수

My positionTop 5%

Low range Average High range

미분류 초소형주 Median 40.2% · Top tier

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

+73.3%

우수

My positionTop 25%

Low range Average High range

미분류 초소형주 Median 25.4% · Top 14%

Past 5-Year Revenue

How much revenue grew over the past 5 years

+3.3%

양호

My positionMid-range

Low range Average High range

미분류 초소형주 Median 2.8% · Top 48%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

+30.7%

우수

My positionTop 25%

Low range Average High range

미분류 초소형주 Median -2.6% · Top 23%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -168%p below the market

COSM -99.8% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-168.2%p

Significantly behind the market

vs Health Care (XLV)

-124.3%p

Significantly behind the sector average

1-year basis

vs S&P 500

-86.6%p

Significantly behind the market

vs Health Care (XLV)

-90.3%p

Significantly behind the sector average

Current position within 52-week range

Low (-26.7%p) High (-84.5%p)

Current price is 26.7% above the 52-week low and 84.5% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-63.8%

Annualized volatility

93.8%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-07-27

Downtrend zone

Current price $0.20 below the midline ($0.24). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴

Current diagnosis · 2026-07-27

Bearish momentum holding

MACD -0.010 < Signal -0.003 in negative zone + Hist negative (-0.007). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-07-27

Bearish zone

RSI 38.8 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 6.3.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Earnings·Vs. Assets·Vs. Sales

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Cheap

🏢 Vs. Assets Cheap

🧾 Vs. Sales Cheap

💵 Vs. Earnings

Forward PER Forward Price-to-Earnings Ratio

PER using next year's estimated earnings — reflects growth

2.92x

✓ Very cheap

My positionTop 25%

Low range Average High range

Healthcare 초소형주 median 11.43x · Top 16% — relatively cheap within the industry

💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

0.51x

✓ Very cheap

My positionTop 25%

Low range Average High range

Healthcare 초소형주 median 1.35x · Top 20% — relatively cheap within the industry

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

0.18x

✓ Very cheap

My positionTop 5%

Low range Average High range

Healthcare 초소형주 median 3.22x · Top 1% — relatively cheap within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

Analyst target price (reference)

$4.50 vs. current price +2150.0%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Healthcare 초소형주

Who owns it?

Ownership backdrop is unfavorable

Insider modest net buying +4.4% · Institutional modest net selling -0.7% · Short interest very high 27.7% · Short interest up +26.3pp over last 90d

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

+4.4%

Insiders net buying

🏦 Institutions (funds & investors)

-0.7%

Institutions net selling

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 2.4%

Retail-led

Healthcare 초소형주 Median 14.2%

🧑‍💼 Insiders 67.5%

Founder/management large holders (strong skin-in-the-game)

Healthcare 초소형주 Median 16.1%

👤 Retail investors (estimated) 30.1%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

27.7%

Very high — strong short-side pressure

Healthcare 초소형주 Median 3.9%

Past 90 days 📈 +26.3%p increase

Short interest days to cover

0.6 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 49.8M주

Float (tradable shares) 20.2M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding COSM

ETFs with the highest weightings · 5 total shown

SCHC

Schwab International Small-Cap Equity ETF

0.03%

$5.4B

VSS

Vanguard FTSE All-World Ex-US Small Capital Index Fund ETF

0.02%

$11.3B

VGK

Vanguard FTSE Europe ETF

0.01%

$29.9B

VXF

Vanguard Extended Market Index ETF

0.00%

$30.4B

VXUS

Vanguard Total International Stock ETF

0.00%

$153.9B

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
COSM This Stock	$12.7M	-	0.5 ▲	-92.33% ▼	-	+2.4%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 코스모스헬스(COSM)?

코스모스헬스(COSM) belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is the market cap of COSM?

The market cap of COSM is approximately $13M, ranking 5,416 within its sector.

What is the 52-week high and low for COSM?

COSM has recorded a 52-week high of $1.32 and a low of $0.16.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.